Efalith

Country: New Zealand

Language: English

Source: Medsafe (Medicines Safety Authority)

Active ingredient:

Lithium succinate 8%{relative} equivalent to 0.85% lithium; Zinc sulfate 0.05%{relative} equivalent to 0.011% zinc

Available from:

Scotia Pharmaceuticals (NZ) Ltd (Ceased operations 14.4.2000)

INN (International Name):

Lithium succinate 8% w/w (Equiv to 0.85% lithium)

Pharmaceutical form:

Topical cream

Composition:

Active: Lithium succinate 8%{relative} equivalent to 0.85% lithium Zinc sulfate 0.05%{relative} equivalent to 0.011% zinc Excipient: Citric acid monohydrate Glyceryl monostearate citrate Phenonip: Phenoxyethanol and hydroxybenzoate Isopropyl myristate Macrogol stearate 2000 Poloxamer 188 Propylene glycol Purified water Sorbitan laurate Stearic acid Trolamine Yellow beeswax

Units in package:

Tube, 5g sample, 5 g

Class:

Prescription

Prescription type:

Prescription

Manufactured by:

Genzyme Ltd

Product summary:

Package - Contents - Shelf Life: Tube, 5g sample - 5 g - 36 months from date of manufacture stored at or below 25°C - Tube, 10g - 10 g - 36 months from date of manufacture stored at or below 25°C - Tube, 20g - 20 g - 36 months from date of manufacture stored at or below 25°C

Authorization date:

1995-03-13